Terms: = Kidney tumors AND ER, estrogen receptor AND Prognosis
30 results:
1. TRIB3 promotes the progression of renal cell carcinoma by upregulating the lipid droplet-associated protein PLIN2.
Li J; Zhang Q; Guan Y; Liao D; Chen H; Xiong H; Sheng Y; Chen X; Pang J
Cell Death Dis; 2024 Apr; 15(4):240. PubMed ID: 38561354
[TBL] [Abstract] [Full Text] [Related]
2. Activating transcription factor 3 is a new biomarker correlation with renal clear cell carcinoma progression.
Yang Z; Hou Y; Li J; Xu D; Yang Z; Wang X
Int J Immunopathol Pharmacol; 2024; 38():3946320241227320. PubMed ID: 38248871
[No Abstract] [Full Text] [Related]
3. Identification and validation of a genetic risk signature associated with prognosis in clear-cell renal cell carcinoma patients.
Lian M; Feng Y; Wu Z; Zheng Z; Liu H; Li J; Yu H; Lian C
Medicine (Baltimore); 2023 Aug; 102(31):e34582. PubMed ID: 37543772
[TBL] [Abstract] [Full Text] [Related]
4. Predicting response of immunotherapy and targeted therapy and prognosis characteristics for renal clear cell carcinoma based on m1A methylation regulators.
Li L; Tan H; Zhou J; Hu F
Sci Rep; 2023 Aug; 13(1):12645. PubMed ID: 37542141
[TBL] [Abstract] [Full Text] [Related]
5. In silico analysis reveals PRDX4 as a prognostic and oncogenic marker in renal papillary cell carcinoma.
Kocatürk B
Gene; 2023 Apr; 859():147201. PubMed ID: 36646187
[TBL] [Abstract] [Full Text] [Related]
6. A pre-operative prognostic model predicting all cause and cause specific mortality for women presenting with invasive breast cancer.
Wang H; Donnan P; Macaskill EJ; Jordan L; Thompson A; Evans A
Breast; 2022 Feb; 61():11-21. PubMed ID: 34891035
[TBL] [Abstract] [Full Text] [Related]
7. Low KIBRA Expression Is Associated with Poor prognosis in Patients with Triple-Negative Breast Cancer.
Kim SW; Chu J; Do SI; Na K
Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441043
[No Abstract] [Full Text] [Related]
8. Syndecan-4 as a Pathogenesis Factor and Therapeutic Target in Cancer.
Onyeisi JOS; Lopes CC; Götte M
Biomolecules; 2021 Mar; 11(4):. PubMed ID: 33810567
[TBL] [Abstract] [Full Text] [Related]
9. Low DAPK1 expression correlates with poor prognosis and sunitinib resistance in clear cell renal cell carcinoma.
Song Z; Li Z; Han W; Zhu C; Lou N; Li X; Luo G; Peng S; Li G; Zhao Y; Guo Y
Aging (Albany NY); 2020 Nov; 13(2):1842-1858. PubMed ID: 33201837
[TBL] [Abstract] [Full Text] [Related]
10. Gremlin-1 augments the oestrogen-related receptor α signalling through EGFR activation: implications for the progression of breast cancer.
Park SA; Sung NJ; Choi BJ; Kim W; Kim SH; Surh YJ
Br J Cancer; 2020 Sep; 123(6):988-999. PubMed ID: 32572171
[TBL] [Abstract] [Full Text] [Related]
11. An integrated PKD1-dependent signaling network amplifies IRE1 prosurvival signaling.
Wu S; Ma S; Yin X; Yi P; Liu J
J Biol Chem; 2019 Jul; 294(29):11119-11130. PubMed ID: 31167779
[TBL] [Abstract] [Full Text] [Related]
12. Plasmacytoid/diffuse urothelial carcinoma: a single-institution immunohistochemical and molecular study of 69 patients.
Perrino CM; Eble J; Kao CS; Whaley RD; Cheng L; Idrees M; Hashemi-Sadraei N; Monn MF; Kaimakliotis HZ; Bandali E; Grignon D
Hum Pathol; 2019 Aug; 90():27-36. PubMed ID: 31054897
[TBL] [Abstract] [Full Text] [Related]
13. [PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer].
Monneur A; Gonçalves A; Bertucci F
Bull Cancer; 2018 Mar; 105(3):263-274. PubMed ID: 29455872
[TBL] [Abstract] [Full Text] [Related]
14. MicroRNA-30a-5p Inhibits the Growth of Renal Cell Carcinoma by Modulating GRP78 Expression.
Wang C; Cai L; Liu J; Wang G; Li H; Wang X; Xu W; Ren M; Feng L; Liu P; Zhang C
Cell Physiol Biochem; 2017; 43(6):2405-2419. PubMed ID: 29073630
[TBL] [Abstract] [Full Text] [Related]
15. Characteristics and prognosis of breast cancer after liver or kidney transplantation.
Jeong IJ; Lee SG; Kim YH; Ko BS; Lee JW; Son BH; Ahn SH; Kim HJ
Breast Cancer Res Treat; 2018 Jan; 167(1):101-106. PubMed ID: 28914398
[TBL] [Abstract] [Full Text] [Related]
16. High TXNDC5 expression predicts poor prognosis in renal cell carcinoma.
Mo R; Peng J; Xiao J; Ma J; Li W; Wang J; Ruan Y; Ma S; Hong Y; Wang C; Gao K; Fan J
Tumour Biol; 2016 Jul; 37(7):9797-806. PubMed ID: 26810069
[TBL] [Abstract] [Full Text] [Related]
17. High ERα36 Expression Level and Membrane Location Predict Poor prognosis in Renal Cell Carcinoma.
Wang Q; Zhang W; Yang J; Liu YL; Yan ZX; Guo ZJ; Li YJ; Bian XW
Medicine (Baltimore); 2015 Jul; 94(26):e1048. PubMed ID: 26131816
[TBL] [Abstract] [Full Text] [Related]
18. Protein kinase D1 regulates ERα-positive breast cancer cell growth response to 17β-estradiol and contributes to poor prognosis in patients.
Karam M; Bièche I; Legay C; Vacher S; Auclair C; Ricort JM
J Cell Mol Med; 2014 Dec; 18(12):2536-52. PubMed ID: 25287328
[TBL] [Abstract] [Full Text] [Related]
19. Discordances in ER, PR and HER2 receptors between primary and recurrent/metastatic lesions and their impact on survival in breast cancer patients.
Yang YF; Liao YY; Yang M; Peng NF; Xie SR; Xie YF
Med Oncol; 2014 Oct; 31(10):214. PubMed ID: 25216864
[TBL] [Abstract] [Full Text] [Related]
20. High expression of KIF26B in breast cancer associates with poor prognosis.
Wang Q; Zhao ZB; Wang G; Hui Z; Wang MH; Pan JF; Zheng H
PLoS One; 2013; 8(4):e61640. PubMed ID: 23585914
[TBL] [Abstract] [Full Text] [Related]
[Next]
